Abstract
Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase, whose activity is inhibited by AKT phosphorylation. This inhibitory phosphorylation of GSK3β can in turn play a regulatory role through phosphorylation of several proteins (such as mTOR, elF2B) to promote protein synthesis. mTOR is a key regulator in protein synthesis and cell proliferation, and recent studies have shown that both GSK3β and mTORC1 can regulate SREBP1 to promote fat synthesis. Thus far, however, the cross talk between GSK3β and the mTOR pathway in the regulation of milk synthesis and associated cell proliferation is not well understood. In this study the interrelationship between GSK3β and the mTOR/S6K1 signaling pathway leading to milk synthesis and proliferation of dairy cow mammary epithelial cells (DCMECs) was analyzed using techniques including GSK3β overexpression by transfection, GSK3β inhibition, mTOR inhibition and methionine stimulation. The analyses revealed that GSK3β represses the mTOR/S6K1 pathway leading to milk synthesis and cell proliferation of DCMECs, whereas GSK3β phosphorylation enhances this pathway. Conversely, the activated mTOR/S6K1 signaling pathway downregulates GSK3β expression but enhances GSK3β phosphorylation to increase milk synthesis and cell proliferation, whereas inhibition of mTOR leads to upregulation of GSK3β and repression of GSK3β phosphorylation, which in turn decreases milk synthesis, and cell proliferation. These findings indicate that GSK3β and phosphorylated GSK3β regulate milk synthesis and proliferation of DCMECs via the mTOR/S6K1 signaling pathway. These findings provide new insight into the mechanisms of milk synthesis.
Highlights
Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase which exists as α and β isoforms.The two isoforms of GSK3 have strongly conserved kinase domains, but differ greatly at theC-terminus
GSK3β plays a role in lipid synthesis: GSK3β inactivation can prevent the degradation of the transcription factor SREBP1 [8,9], which is considered a global regulator of lipid metabolism [10,11]
lithium chloride (LiCl) treatment led to significantly increased TG secretion in the culture supernatant of dairy cow mammary epithelial cells (DCMECs) (Figure 2E). These results indicate that GSK3β inhibition enhances GSK3β phosphorylation and the mTOR/S6K1 signaling pathway leading to milk synthesis and increases proliferation of DCMECs
Summary
Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase which exists as α and β isoforms.The two isoforms of GSK3 have strongly conserved kinase domains, but differ greatly at theC-terminus. GSK3β plays an important physiological role in the regulation of a wide range of cellular functions including differentiation, growth, apoptosis, and cell response to stimuli [1,2,3]; and GSK3β inactivation or depletion has been shown to promote β-cell proliferation [4]. GSK3β is essential for the degradation of CyclinD1, which is an important regulator of G1/S phase cell cycle transition [6]; and in HepG2 and HeLa cells, AKT is known to inactivate GSK3β [7]. GSK3β plays a role in lipid synthesis: GSK3β inactivation can prevent the degradation of the transcription factor SREBP1 [8,9], which is considered a global regulator of lipid metabolism [10,11].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.